Net profit of Bafna Pharmaceuticals rose 54.04% to Rs 2.48 crore in the quarter ended September 2023 as against Rs 1.61 crore during the previous quarter ended September 2022. Sales rose 85.25% to Rs 40.68 crore in the quarter ended September 2023 as against Rs 21.96 crore during the previous quarter ended September 2022.
| Particulars | Quarter Ended |
| | Sep. 2023 | Sep. 2022 | % Var. |
| Sales | 40.68 | 21.96 | 85 |
| OPM % | 9.83 | 11.57 | - |
| PBDT | 3.72 | 2.73 | 36 |
| PBT | 2.48 | 1.61 | 54 |
| NP | 2.48 | 1.61 | 54 |